Integrated Biopharma Inc (INBP)
CIK 1016504 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Integrated Biopharma Inc.
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Aug 20, 2026 | 8-K | 0001437749-26-028628 |
| Jul 2, 2026 | 8-K | 0001437749-26-022415 |
| Jun 25, 2026 | 4 | 0001345281-26-000008 |
| Jun 25, 2026 | 4 | 0001443194-26-000006 |
| Jun 25, 2026 | 4/A | 0001216280-26-000002 |
| Jun 25, 2026 | 4 | 0001216280-26-000001 |
| Jun 25, 2026 | 4 | 0001382218-26-000001 |
| May 8, 2026 | 10-Q | 0001437749-26-015899 |
| May 8, 2026 | 8-K | 0001437749-26-015928 |
| Apr 17, 2026 | SCHEDULE 13D/A | 0001102948-26-000006 |
| Apr 17, 2026 | 4 | 0001345281-26-000004 |
| Apr 17, 2026 | 4 | 0001102948-26-000002 |
| Apr 17, 2026 | 4 | 0001443194-26-000004 |
| Apr 17, 2026 | SCHEDULE 13D | 0001345281-26-000007 |
| Apr 17, 2026 | 4/A | 0001443194-26-000005 |
| Apr 15, 2026 | 8-K | 0001437749-26-012368 |
| Mar 26, 2026 | 4 | 0001102948-26-000001 |
| Mar 25, 2026 | 4 | 0001443194-26-000003 |
| Mar 25, 2026 | 4 | 0001345281-26-000001 |
| Feb 18, 2026 | 8-K | 0001437749-26-004553 |
| Feb 11, 2026 | 10-Q | 0001437749-26-003803 |
| Feb 11, 2026 | 8-K | 0001437749-26-003808 |
| Dec 10, 2025 | 4 | 0001064900-25-000002 |
| Dec 10, 2025 | 4 | 0001345281-25-000011 |
| Dec 10, 2025 | 4 | 0001064901-25-000002 |